FDA Food and Drug Administration - Search News

FDA, Axsome and migraine

Hosted on MSN · 6h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The oral drug, branded Symbravo, was approved for the acute treatment of the condition characterized by recurrent attacks of moderate to severe throbbing and pulsating pain on one side of the head.

Business Insider · 9h

Axsome Therapeutics announces FDA approval of Symbravo

Axsome Therapeutics (AXSM) announced that the U.S. FDA has approved Symbravo for the acute treatment of migraine with or without aura in

Investing.com on MSN · 8h

FDA approves new migraine treatment SYMBRAVO

NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue growth over the last twelve months, announced the U.S. Food and Drug Administration (FDA) has approved SYMBRAVO®,

Seeking Alpha on MSN · 8h

Axsome gets FDA approval for Symbravo for migraine

Axsome Therapeutics (NASDAQ:AXSM) has received FDA approval for its drug Symbravo for the acute treatment of migraine with or without aura in adults. Symbravo, a combination of meloxicam and rizatriptan,

1st New Non-Opioid Painkiller in Decades Gets FDA Approval

FDA approves new type of non-opioid pain medication

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is

FDA approves new type of non-opioid pain medication, 1st of its kind in more than 20 years

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.

New Atlas · 3h

FDA approves new class of painkiller – the first in more than 20 years

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years,

FDA upgrades Frito-Lay recall to highest priority

This chocolate recall has been upgraded to FDA’s highest risk level

STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.”

Houston Chronicle · 1d

FDA upgrades Frito-Lay recall to highest priority; Texas not affected

The Food and Drug Administration has upgraded a December recall of Classic Lays Potato Chips to Class 1, the highest priority designated by the agency.

Lays Classic Potato Chip recall upgraded to highest level. What to know

"Those with an allergy or...sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume the recalled product."

WISH-TV on MSN7h

FDA redefines ‘healthy’ food labels to help consumers make informed choices

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...

1don MSN

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks

Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.

Opinion

Havasu News1hOpinion

Chicago Tribune: Not all ‘processed’ food is bad — but Red Dye No. 3 doesn’t belong in what we eat

Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results